{
    "id": 7543,
    "fullName": "TSC1 loss",
    "impact": "unknown",
    "proteinEffect": "loss of function",
    "geneVariantDescriptions": [
        {
            "description": "TSC1 loss indicates loss of the TSC1 gene, mRNA, and protein.",
            "references": [
                {
                    "id": 275,
                    "pubMedId": null,
                    "title": "External Reference Not Available (N/A)",
                    "url": "https://ckb.jax.org/about/glossaryOfTerms"
                }
            ]
        }
    ],
    "type": "non-specific",
    "gene": {
        "id": 7248,
        "geneSymbol": "TSC1",
        "terms": [
            "TSC1",
            "LAM",
            "TSC"
        ]
    },
    "variant": "loss",
    "createDate": "06/11/2015",
    "updateDate": "09/19/2019",
    "referenceTranscriptCoordinates": null,
    "partnerGenes": [
        
    ],
    "evidence": [
        {
            "id": 2395,
            "approvalStatus": "Preclinical",
            "evidenceType": "Actionable",
            "efficacyEvidence": "In a preclinical study, Rapamune (sirolimus) inhibited proliferation of cultured bladder cancer cells lacking TSC1 (PMID: 23401075).",
            "molecularProfile": {
                "id": 7422,
                "profileName": "TSC1 loss"
            },
            "therapy": {
                "id": 917,
                "therapyName": "Sirolimus",
                "synonyms": null
            },
            "indication": {
                "id": 11054,
                "name": "urinary bladder cancer",
                "source": "DOID"
            },
            "responseType": "sensitive",
            "references": [
                {
                    "id": 993,
                    "pubMedId": 23401075,
                    "title": "TSC1 involvement in bladder cancer: diverse effects and therapeutic implications.",
                    "url": "http://www.ncbi.nlm.nih.gov/pubmed/23401075"
                }
            ],
            "ampCapAscoEvidenceLevel": "D",
            "ampCapAscoInferredTier": "II"
        },
        {
            "id": 2398,
            "approvalStatus": "Preclinical",
            "evidenceType": "Actionable",
            "efficacyEvidence": "In a preclinical study, Luminespib (AUY922), in combination with Torin 1 inhibited growth of bladder cancer cells lacking TSC1 to a greater extent than either therapy alone (PMID: 23401075).",
            "molecularProfile": {
                "id": 7422,
                "profileName": "TSC1 loss"
            },
            "therapy": {
                "id": 2828,
                "therapyName": "Luminespib + Torin 1",
                "synonyms": null
            },
            "indication": {
                "id": 11054,
                "name": "urinary bladder cancer",
                "source": "DOID"
            },
            "responseType": "sensitive",
            "references": [
                {
                    "id": 993,
                    "pubMedId": 23401075,
                    "title": "TSC1 involvement in bladder cancer: diverse effects and therapeutic implications.",
                    "url": "http://www.ncbi.nlm.nih.gov/pubmed/23401075"
                }
            ],
            "ampCapAscoEvidenceLevel": "D",
            "ampCapAscoInferredTier": "II"
        },
        {
            "id": 2397,
            "approvalStatus": "Preclinical",
            "evidenceType": "Actionable",
            "efficacyEvidence": "In a preclinical study, Luminespib (AUY922), in combination with Rapamune (sirolimus), inhibited growth of bladder cancer cells lacking TSC1 to a greater extent than either therapy alone (PMID: 23401075).",
            "molecularProfile": {
                "id": 7422,
                "profileName": "TSC1 loss"
            },
            "therapy": {
                "id": 2827,
                "therapyName": "Luminespib + Sirolimus",
                "synonyms": null
            },
            "indication": {
                "id": 11054,
                "name": "urinary bladder cancer",
                "source": "DOID"
            },
            "responseType": "sensitive",
            "references": [
                {
                    "id": 993,
                    "pubMedId": 23401075,
                    "title": "TSC1 involvement in bladder cancer: diverse effects and therapeutic implications.",
                    "url": "http://www.ncbi.nlm.nih.gov/pubmed/23401075"
                }
            ],
            "ampCapAscoEvidenceLevel": "D",
            "ampCapAscoInferredTier": "II"
        },
        {
            "id": 2396,
            "approvalStatus": "Preclinical",
            "evidenceType": "Actionable",
            "efficacyEvidence": "In a preclinical study, Torin 1 inhibited proliferation of cultured bladder cancer cells lacking TSC1 (PMID: 23401075).",
            "molecularProfile": {
                "id": 7422,
                "profileName": "TSC1 loss"
            },
            "therapy": {
                "id": 2247,
                "therapyName": "Torin 1",
                "synonyms": null
            },
            "indication": {
                "id": 11054,
                "name": "urinary bladder cancer",
                "source": "DOID"
            },
            "responseType": "sensitive",
            "references": [
                {
                    "id": 993,
                    "pubMedId": 23401075,
                    "title": "TSC1 involvement in bladder cancer: diverse effects and therapeutic implications.",
                    "url": "http://www.ncbi.nlm.nih.gov/pubmed/23401075"
                }
            ],
            "ampCapAscoEvidenceLevel": "D",
            "ampCapAscoInferredTier": "II"
        }
    ],
    "molecularProfiles": [
        {
            "id": 7422,
            "profileName": "TSC1 loss",
            "profileTreatmentApproaches": [
                {
                    "id": 5309,
                    "name": "mTORC1 Inhibitor",
                    "profileName": "TSC1 loss"
                },
                {
                    "id": 5308,
                    "name": "mTOR Inhibitor",
                    "profileName": "TSC1 loss"
                }
            ]
        }
    ],
    "allTranscriptCoordinates": [
        
    ]
}